Thermal Partial Prostate Ablation for Intermediate- and High-risk Prostate Cancer: Con

被引：1
|
作者：
Gaffney, Christopher D. [1 ]
Ehdaie, Behfar [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA
来源：
EUROPEAN UROLOGY FOCUS | 2023年 / 9卷 / 04期
关键词：
PARTIAL GLAND ABLATION; RADICAL PROSTATECTOMY; FOCUSED ULTRASOUND; FOCAL THERAPY; OUTCOMES;
D O I：
10.1016/j.euf.2022.12.009
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：660 / 661
页数：2
相关论文
共 50 条
  • [1] Localized intermediate- to high-risk prostate cancer
    Tritschler, S.
    Ganswindt, U.
    Stief, C. G.
    UROLOGE, 2016, 55 (03): : 318 - +
  • [2] Focal therapy in intermediate- and high-risk prostate cancer
    Nicolai A. Huebner
    Stephan Korn
    Pawel Rajwa
    Shahrokh F. Shariat
    memo - Magazine of European Medical Oncology, 2023, 16 : 247 - 250
  • [3] Focal therapy in intermediate- and high-risk prostate cancer
    Huebner, Nicolai A.
    Korn, Stephan
    Rajwa, Pawel
    Shariat, Shahrokh F.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (04) : 247 - 250
  • [4] Molecular correlates of intermediate- and high-risk localized prostate cancer
    Ye, Huihui
    Sowalsky, Adam G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 368 - 374
  • [5] Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer
    Zumsteg, Zachary S.
    Zelefsky, Michael J.
    Woo, Kaitlin M.
    Spratt, Daniel E.
    Kollmeier, Marisa A.
    McBride, Sean
    Pei, Xin
    Sandler, Howard M.
    Zhang, Zhigang
    BJU INTERNATIONAL, 2017, 120 (5B) : E87 - E95
  • [6] Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer
    Yuh, Bertram E.
    Ruel, Nora H.
    Mejia, Rosa
    Wilson, Chelsea M.
    Wilson, Timothy G.
    EUROPEAN UROLOGY, 2012, 61 (05) : 1004 - 1010
  • [7] A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
    Armstrong, Andrew J.
    Netto, George J.
    Rudek, Michelle A.
    Halabi, Susan
    Wood, David P.
    Creel, Patricia A.
    Mundy, Kelly
    Davis, S. Lindsay
    Wang, Ting
    Albadine, Roula
    Schultz, Luciana
    Partin, Alan W.
    Jimeno, Antonio
    Fedor, Helen
    Febbo, Phillip G.
    George, Daniel J.
    Gurganus, Robin
    De Marzo, Angelo M.
    Carducci, Michael A.
    CLINICAL CANCER RESEARCH, 2010, 16 (11) : 3057 - 3066
  • [8] Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?
    Lee, Hye Won
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Choi, Han Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (11) : 1631 - 1637
  • [9] Brachytherapy Increased use in patients with intermediate- and high-risk prostate cancers
    Ali, Sanna
    Esper, Peg
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (03) : 321 - 328
  • [10] Is Clinical Stage T2c Prostate Cancer an Intermediate- or High-Risk Disease?
    Klaassen, Zachary
    Singh, Abhay A.
    Howard, Lauren E.
    Feng, Zhaoyong
    Trock, Bruce
    Terris, Martha K.
    Aronson, William J.
    Cooperberg, Matthew R.
    Amling, Christopher L.
    Kane, Christopher J.
    Partin, Alan
    Han, Misop
    Freedland, Stephen J.
    CANCER, 2015, 121 (09) : 1414 - 1421
12345